PDFF Biomarker Ctte: Difference between revisions
Jump to navigation
Jump to search
| (33 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
:Co-chairs: Scott Reeder, MD, PhD, Takeshi Yokoo, MD, PhD | :Co-chairs: Scott Reeder, MD, PhD, Takeshi Yokoo, MD, PhD | ||
: | :RSNA Staff Support: Susan Stanfa | ||
* [ | * [https://docs.google.com/spreadsheets/d/e/2PACX-1vQZBtnrVMpQOU8BEKlY_4hs21JQoEhq_926-HCFtPm77AHzJ3-dp_S6cedeDfbIIILljxJVongZMJsb/pubhtml?gid=1460430101&single=true Roster] | ||
The PDFF Biomarker Committee seeks to develop a quantitative Profile for PDFF. | The PDFF Biomarker Committee seeks to develop a quantitative Profile for PDFF. | ||
==Meetings== | |||
[[PDFF Biomarker Committee Call Summaries Archive]] | '''Approved call summaries:''' | ||
<br />Notes are posted after they are approved by the PDFF BC during the following t-con. The last meeting was on February 3, 2022. | |||
*[[Media:2021_04-01_QIBA_PDFF_BC_Meeting_Summary-FINAL.pdf|April 1, 2021]] | |||
*[[Media:2021_02-04_QIBA_PDFF_BC_Call_Summary-FINAL.pdf|February 4, 2021]] | |||
*[[Media:2021_01-07_QIBA_PDFF_BC_Call_Summary-FINAL.pdf|January 7, 2021]] | |||
'''''[[PDFF Biomarker Committee Call Summaries Archive]]''''' | |||
==Working Documents== | ==Working Documents== | ||
Latest revision as of 14:53, 7 February 2022
- Co-chairs: Scott Reeder, MD, PhD, Takeshi Yokoo, MD, PhD
- RSNA Staff Support: Susan Stanfa
The PDFF Biomarker Committee seeks to develop a quantitative Profile for PDFF.
Meetings
Approved call summaries:
Notes are posted after they are approved by the PDFF BC during the following t-con. The last meeting was on February 3, 2022.
PDFF Biomarker Committee Call Summaries Archive